The Mission Within
- Company typePrivate
- Founded2017
- HeadquartersAustin, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
The Mission Within firmographics
Firmographics- Name
- The Mission Within
- Legal name
- Elite Neuro Recovery Center
- Website
- https://missionwithin.org
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
The Mission Within industry classification
Industry- Product category
- Psychedelic Therapy Services
- NAICS
- Residential Mental Health and Substance Abuse Facilities (623220)
- SIC
- Services-Health Services (8000), Hotels, Rooming Houses, Camps & Other Lodging Places (7000)
- akta.pro primary industry
- Rehabilitation & Recovery Retreats (Physio, Post-Op, Pain Management) (THAGAMAG)
- akta.pro secondary industry
- Holistic & Alternative Therapy Retreats (Naturopathy, Energy Work) (THAGAMAI)
Keywords
Where The Mission Within is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
The Mission Within business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Clinical Treatment Program Fees: The primary revenue stream comes from fees charged for the comprehensive 6-week clinical psychedelic program, which includes preparation coaching, the in-person medicine retreat with Ibogaine and 5-MeO treatments, integration coaching, room and board, 24-hour medical support, and transportation from San Diego. Pricing varies by customer segment: $6,500 for US Veterans and $7,500 for Civilians, plus a $75 initial Health Screen fee.
- Donations and Foundation Support: The company raises funds through Mission to Live Foundation, a nonprofit that provides scholarships and financial assistance for veterans and first responders who cannot afford the treatment fee. Donations are accepted via the foundation's website.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | US Veterans Program - Full 6-week clinical psychedelic treatment including preparation, 5-day in-person retreat with Ibogaine and 5-MeO, integration coaching, and aftercare |
| Unit Pricing | Pay-as-you-go | Civilian Program - Full 6-week clinical psychedelic treatment including preparation, 5-day in-person retreat with Ibogaine and 5-MeO, integration coaching, and aftercare |
| Unit Pricing | Pay-as-you-go | Health Screening Fee |
| Other | Pay-as-you-go | Veterans/First Responder Financial Assistance |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
The Mission Within product offering
Product offeringCore offering
The Mission Within provides a 6-week clinical psychedelic therapy program that pairs online preparation coaching, a 5-day in-person medicine retreat, and post-retreat integration coaching. The in-person retreat uses sequential administration of Ibogaine and 5-MeO-DMT under 24-hour medical supervision to treat PTSD, mTBI, depression, anxiety, and addiction in veterans, first responders, military families, and high-performance individuals. The program is delivered at a facility in coastal Mexico near San Diego.
Product overview
The Mission Within offers a single unified clinical offering: the 6-Week Clinical Psychedelic Program, which pairs online therapy, coaching, preparation, and integration with a 5-day in-person medicine retreat in Mexico. The core treatment protocol centers on two psychedelic medicines — Ibogaine (administered in an overnight ceremony) and 5-MeO (administered in individual inhalation sessions) — used sequentially, with psilocybin also mentioned as part of the entheogen portfolio. The program is supported by structured add-on modules: Preparation Coaching (minimum 2 sessions), Integration Coaching (minimum 3 sessions), a Preparation and Integration Workbook, and Aftercare Resources & Community. The organization also operates two supplemental initiatives: Healing Across Borders (a humanitarian program for conflict-affected populations globally) and Mission to Live Foundation (a nonprofit scholarship and research fund). Together, these form a clinical treatment program built around the sequential Ibogaine + 5-MeO protocol pioneered by Dr. Martín Polanco.
Differentiator
Problem solved
Functional benefit
Brands
- Mission to Live Foundation: Nonprofit foundation established in 2025 to raise funds for scholarships and support cutting-edge research for psychedelic therapy access for veterans and first responders.
Products and services
- 6-Week Clinical Psychedelic Program A 6-week clinical psychedelic program pairing online therapy, coaching, preparation, and integration with a 5-day in-person medicine retreat in Mexico, using sequential Ibogaine and 5-MeO-DMT treatments within a trauma-informed, peer-community framework. Priced at $6,500 for US Veterans and $7,500 for Civilians, plus a $75 Health Screen fee. Designed for individuals dealing with PTSD, mTBI, depression, anxiety, and addiction who have not found relief through conventional medicine.
- Ibogaine Treatment A clinical treatment using ibogaine, an alkaloid derived from the root bark of Tabernanthe iboga, administered in a long (24+ hour) ceremony to address addiction, PTSD, and traumatic brain injury. Forms the first stage of The Mission Within's sequential protocol.
- 5-MeO Treatment A clinical treatment using 5-MeO-DMT, a fast-acting psychedelic typically inhaled as vaporized toad-derived or synthetic material, administered in individual sessions to produce ego dissolution and mystical experiences for PTSD, depression, and trauma recovery. Delivered as the second stage of the sequential Ibogaine + 5-MeO protocol.
- Psilocybin Treatment A clinical treatment using psilocybin, a psychedelic compound found in Psilocybe mushrooms, used in The Mission Within's treatments alongside Ibogaine and 5-MeO-DMT and subject to the same waiver and safety protocols.
- Healing Across Borders A humanitarian initiative providing trauma recovery services for individuals impacted by war and conflict worldwide, including Israeli veterans and civilians, and Palestinian civilians and refugees, delivered through regionally focused treatment cohorts that meet medical and safety criteria.
- Mission to Live Foundation Scholarship Program A nonprofit foundation that provides scholarships and financial assistance for veterans and first responders to access The Mission Within's treatment program, and supports cutting-edge psychedelic research. Operated as a separate 501(c)(3) entity under the Mission to Live Foundation brand.
Quantifiable outcome
- 80% of participants no longer meet diagnostic criteria for PTSD after treatment
- +5 more outcomes
Companies that use The Mission Within
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles4 records
The Mission Within technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
The Mission Within partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- UT Austin Dell Medical School - Center for Psychedelic Research and TherapycoreActive research partnership examining how ibogaine and psilocybin affect brain function and mental health outcomes in veterans and military-connected communities. Two ongoing studies: (1) Ibogaine Study for Special Operations Veterans examining neurological and psychological effects with longer assessment timelines and ibogaine-only controls, (2) Psilocybin Therapy for Surviving Family Members examining brain function and grief recovery with MRI imaging.
- Stanford UniversitycoreCollaboration on research examining outcomes related to PTSD, mTBI, and alcohol use disorder. Dr. Polanco has presented findings at Stanford and collaborated with researchers from the Brain Stimulation Lab.
- Harvard Medical SchoolcoreCollaborative research relationship on studying outcomes related to PTSD, mTBI, and related conditions in veteran populations.
- Yale UniversitycoreAcademic collaboration on research studying outcomes related to PTSD, mTBI, and trauma in veteran populations.
- National Intrepid Center of Excellence (NICoE)corePresentation and collaboration with NICoE, which is part of the Defense Health Agency focused on traumatic brain injury and psychological health for service members.
- Mission to Live FoundationcoreNonprofit founded by Dr. Polanco in 2025 to remove financial barriers to treatment for veterans and first responders. The foundation raises funds for scholarships, contributes to cutting-edge research, and advocates for greater accessibility to psychedelic therapy.
- Crossroads Treatment CenterminorFormer clinic operated by Dr. Polanco in Tijuana (2012) where early research on ibogaine and 5-MeO was conducted. Dr. Joseph Barsuglia was recruited as Research Director in 2015 to begin systematic data collection.
- Ibogaine Association (Mexico)minorOne of the first medically supervised ibogaine clinics on the American continent, co-founded by Dr. Polanco in 2000.
- Special Operations Medical Association (SOMA)minorPresented research findings at the SOMA Scientific Assembly on psychedelic treatment outcomes for Special Operations Forces veterans.
- U.S. Department of DefenseminorPresented findings on psychedelic treatment for trauma at Department of Defense forums and grand rounds.
- World Economic ForumminorDr. Polanco presented findings at the World Economic Forum, positioning the organization's work in the global health policy conversation.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
The Mission Within competitors and assessment
Company assessmentEmerging players
- MindMed: Public psychedelic medicine company developing LSD and MDMA-based therapies for anxiety, ADHD, and other conditions. Comparable as a regulated psychedelic clinical developer pursuing FDA pathways; differs from Mission Within in targeting outpatient drug development rather than retreat-based delivery.
- Compass Pathways: Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Comparable as a regulated, well-capitalized psychedelic therapy developer targeting psychiatric indications, though focused on psilocybin rather than ibogaine/5-MeO and based in the UK/US rather than a Mexico retreat.
- atai Life Sciences: Public platform company developing multiple psychedelic compounds (psilocybin, DMT, ibogaine derivatives) for mental health. Comparable as a well-capitalized ibogaine-adjacent developer; differs from Mission Within as a clinical-stage pharma platform rather than a retreat operator.
Others
- Stanford Psychedelic Science Group: Academic research group at Stanford Medicine studying psilocybin and other psychedelics for psychiatric conditions. Listed as a research partner of The Mission Within and a comparable node in the academic psychedelic research ecosystem.
- Multidisciplinary Association for Psychedelic Studies (MAPS): Nonprofit research organization that pioneered MDMA-assisted therapy clinical trials and PTSD research. Comparable as a leading psychedelic research and advocacy organization with veteran PTSD focus; differs as a research/advocacy nonprofit rather than a treatment provider.
Broad incumbents
- Mindbloom: US ketamine therapy provider delivering at-home and clinic-based sessions for depression, anxiety, and PTSD. Comparable as a scaled psychedelic-adjacent therapy provider targeting mental health; differs by using ketamine (legal in US) rather than ibogaine, with a more distributed clinic model.
Direct peers
- Beond Ibogaine: Mexico-based medically supervised ibogaine treatment center for addiction and mental health conditions. Most directly comparable peer: same compound (ibogaine), similar location (Mexico), similar clinical retreat model, and overlapping customer segments including veterans and trauma patients.
- Clear Sky Recovery: Ibogaine-focused addiction treatment clinic in Cancun, Mexico. Directly comparable as a Mexico-based ibogaine clinic offering supervised treatment for substance use disorders; smaller scale and less veteran focus than Mission Within.
- Field Trip Health (now Field Trip): Previously operated ketamine-assisted psychotherapy clinics across North America before restructuring. Comparable as a clinic-based psychedelic therapy operator pursuing trauma and depression indications; differs in compound (ketamine), geographic footprint, and operational scale.
Regional players
- Veterans Healing Network (Cohen Veterans Network): Nonprofit network of mental health clinics providing free therapy to veterans and military families across the US. Comparable as a veteran-focused mental health provider; differs by offering conventional outpatient therapy rather than psychedelic-assisted treatment.
Market position
Strengths5 records
Weaknesses6 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
The Mission Within social profiles
Digital presenceThe Mission Within financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Mission Within leadership team
Management profileNumber of profiles
Profiles1 record
The Mission Within funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Mission Within M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Mission Within
What does The Mission Within do?
The Mission Within provides a 6-week clinical psychedelic therapy program that pairs online preparation coaching, a 5-day in-person medicine retreat, and post-retreat integration coaching. The in-person retreat uses sequential administration of Ibogaine and 5-MeO-DMT under 24-hour medical supervision to treat PTSD, mTBI, depression, anxiety, and addiction in veterans, first responders, military families, and high-performance individuals. The program is delivered at a facility in coastal Mexico near San Diego.
Is The Mission Within a public or private company?
The Mission Within is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was The Mission Within founded?
The Mission Within was founded in 2017. It employs 11 to 50 people.
Where is The Mission Within based?
The Mission Within is headquartered in Austin, United States, in the North America region.
How does The Mission Within make money?
Two revenue lines are on record. Clinical Treatment Program Fees are the primary driver. The others are donations and Foundation Support.
Who are The Mission Within's main competitors?
Emerging players on record are MindMed, Compass Pathways and atai Life Sciences. Others are Stanford Psychedelic Science Group and Multidisciplinary Association for Psychedelic Studies (MAPS). Mindbloom is listed as a broad incumbent. Direct peers are Beond Ibogaine, Clear Sky Recovery and Field Trip Health (now Field Trip). Veterans Healing Network (Cohen Veterans Network) is listed as a regional player.
Does The Mission Within have an API?
No public API is recorded for The Mission Within.
What industry is The Mission Within in?
The Mission Within's product category is Psychedelic Therapy Services. Its primary akta.pro industry code is THAGAMAG, Rehabilitation & Recovery Retreats (Physio, Post-Op, Pain Management), with a secondary code of THAGAMAI, Holistic & Alternative Therapy Retreats (Naturopathy, Energy Work). Its NAICS code is 623220 and its SIC code is 8000.